Dr. Michael A. Curi, MD
Vascular Surgery (Vascular Surgery Physician)
90 Bergen St, Division Of Vascular Surgery Suite 7100
Newark, NJ 07103
Who else practices at this address →
Essex County includes primary care (34% of residents) and mental health (11% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Rutgers New Jersey Medical School (1998)
- Years since graduation
- 28
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 204
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1998Medical school: Rutgers New Jersey Medical School
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Vascular Surgery Physician primary
NJ license 25MA08741000
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Jersey City Medical Center Jersey City, NJ
- The University Hospital Newark, NJ
Medical groups
- University Physician Associates of New Jersey Inc (378 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 204
- Services billed
- 412
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| Ultrasound study of arm or leg veins with compression and maneuvers | 60 | 57 |
| Established patient office or other outpatient visit, 20-29 minutes | 41 | 30 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 22 | 21 |
| Established patient office or other outpatient visit, 30-39 minutes | 17 | 14 |
| Ultrasound of hemodialysis access | 17 | 12 |
| Ultrasound study of arm and leg arteries | 16 | 14 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 15 | 15 |
| Ultrasound of both sides of head and neck blood flow | 14 | 14 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Newark, NJ | 22 |
| Eliquis (apixaban) Other prescribers in Newark, NJ | 18 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 12 companies reported 28 payments worth $24,268 in total to this clinician.
| Humacyte Global, Inc. | $22,674 |
|---|---|
| Endologix LLC | $448 |
| Cook Medical LLC | $377 |
| W. L. Gore & Associates, Inc. | $332 |
| Kerecis Limited | $134 |
| Boston Scientific Corporation | $128 |
| Bolton Medical Inc | $74.67 |
| Shockwave Medical, Inc | $33.95 |
| Consulting Fee | $19,800 |
|---|---|
| Food and Beverage | $2,322 |
| Travel and Lodging | $2,146 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Humacyte Global, Inc. Dec 19, 2025 | Consulting Fee Symvess · Extremity Arterial Injury | $11,200 |
| Humacyte Global, Inc. Jul 11, 2025 | Consulting Fee Symvess · Extremity Arterial Injury | $6,800 |
| Humacyte Global, Inc. Dec 19, 2025 | Travel and Lodging Symvess · Extremity Arterial Injury · travel to San Antonio, TX | $2,146 |
| Humacyte Global, Inc. Aug 21, 2025 | Consulting Fee Symvess · Extremity Arterial Injury | $1,800 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $11,063 in research payments for these studies, mostly to the institutions running them.
- Humacyte Acellular Tissue Engineered Vessel (ATEV) in Patients With Vascular Trauma
Humacyte Global, Inc. · Completed · NCT03005418 - To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis
Humacyte Global, Inc. · Active, not recruiting · NCT05908084
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.